Clinical trial · Interventional
Improving Adherence to Recommended Surveillance in Breast Cancer Survivors
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Evidence-based guidelines recommend cancer surveillance procedures for breast cancer survivors including physical examination, mammography, breast self-exam, and gynecologic follow-up. The early detection of recurrent and new cancers can best be achieved through the combined, on schedule use of these surveillance procedures. Yet, data suggest that up to 55% of breast cancer survivors do not undergo these procedures as recommended. This study tests a telephone-based psychosocial intervention aimed at improving adherence to recommended surveillance in breast cancer survivors. The psychosocial intervention for improving adherence is compared to treatment as usual.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Breast Cancer | Malignant Breast Neoplasm | CURATED_EXACT | 0.92 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Psychosocial Intervention | Behavioral | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- EXPERIMENTAL
- label
- Psychosocial Intervention
- description
- Telephone-based psychosocial intervention involving six telephone encounters. Each encounter focuses on teaching skills for improving adherence and overcoming barriers to obtaining recommended surveillance.
- interventionNames
- Behavioral: Psychosocial Intervention
- type
- NO_INTERVENTION
- label
- Treatment as usual
- description
- Treatment as usual control.
Primary outcomes (1)
- measure
- Surveillance adherence
- timeFrame
- 15 month follow-up
- description
- Receipt of recommended mammograms and clinical breast exams (coded 0=no, 1=yes)
Eligibility
Eligibility (as posted)
- Sex
- Female
- Minimum age
- 21 Years
Show eligibility criteria text
Inclusion Criteria: * 21 years of age or older * Diagnosis of Stage I to IIIA breast cancer * Within 1 to 5 years post primary cancer treatment (i.e., surgery, chemotherapy, and/or radiation therapy) * No diagnosis of recurrent breast cancer or a new primary cancer * Able to provide meaningful consent Exclusion Criteria: * \< 21 years of age * Unable to provide meaningful consent * Surgically treated with bilateral mastectomy
References
Publications (0)
Data not yet available